Knowledge Centre
category guide

How to Choose Catheterization Lab Equipment

May 2, 2026· 11 min read· AI-generated

How to Choose Catheterization Lab Equipment

What hospital cardiology programs, ASC administrators, and interventional teams need to know before committing $1M–$5M to a cath lab build or upgrade.


What this is and who buys it

A cardiac catheterization laboratory is not a single device — it is an integrated procedural suite, and that distinction matters enormously for procurement. At minimum, a functional cath lab requires a fluoroscopic C-arm with a flat-panel detector (FPD), a hemodynamic monitoring and recording system (the "polygraph"), a contrast media power injector, a floating isocentric patient table, and imaging workstations connected to the facility's PACS. In practice, commissioning a new lab means coordinating equipment from two or more vendors, a construction contractor, and your IT/informatics team — simultaneously.

The primary buyers are hospital-based cardiology service lines, academic medical centers, high-volume ambulatory surgery centers (ASCs) credentialed for interventional cardiology, and community hospitals either launching or upgrading a cardiovascular program. The procedures these labs support range from routine diagnostic coronary angiography and percutaneous coronary intervention (PCI) to more complex work: structural heart procedures such as transcatheter aortic valve implantation (TAVI), and electrophysiology (EP) studies requiring biplane imaging capability.

Procurement decisions typically cluster around a few triggers: a new program launch, end-of-service-life on an existing system (most cath lab platforms carry a realistic clinical lifespan of 10–15 years), significant growth in procedure volume that saturates an existing room, or clinical expansion into structural heart or EP that demands imaging capability the current system cannot provide. Each trigger implies a different capital envelope and a different risk profile, and conflating them is one of the more common planning errors in cath lab procurement.


Key decision factors

Single-plane vs. bi-plane configuration is the first fork in the road. A single-plane system — one C-arm, one detector — handles well over 80% of routine diagnostic angiography and PCI cases, and it comes in at roughly 40–50% lower capital cost than a bi-plane equivalent. Bi-plane systems, which provide two simultaneous imaging angles through independent C-arm assemblies, are genuinely required for complex EP mapping, neurointerventional work, pediatric cardiology, and most structural heart programs. Buying bi-plane capability speculatively, without a defined program to support it, is an expensive mistake; buying single-plane when your electrophysiologists need biplane is a clinical one.

Flat-panel detector size and generation directly affects both procedural versatility and your financial exposure on repairs. A standard cardiac-dedicated FPD is roughly 20×20 cm² — adequate for coronary work. Intermediate (~30 cm²) and large-format (30×40 cm² or 41 cm²) panels broaden the system's utility across peripheral vascular and general angiography, but add to acquisition cost. What procurement teams consistently underestimate is the cost of FPD failure: a single detector replacement can run $80,000–$200,000. On any refurbished system, verifying the detector's age, documented history, and remaining warranty coverage is not optional due diligence — it is the financial crux of the purchase.

Image chain technology defines both clinical image quality and dose efficiency. Modern FPD-based systems provide higher spatial resolution, lower radiation dose to both patient and staff, no geometric distortion, and native 3D rotational angiography capability. Legacy image intensifier (II)-based systems — still encountered in some refurbished offerings — cannot match these benchmarks. Unless you are operating a very low-volume diagnostic-only program with an extremely constrained capital budget, a refurbished II-based system is difficult to justify clinically or operationally in 2024.

Hemodynamic monitoring integration is a function procurement teams sometimes treat as secondary to the X-ray platform, which is a mistake. The polygraph must continuously capture 12-lead ECG, invasive arterial pressure via at least two independent transducers, SpO₂, cardiac output, and full hemodynamic waveform data, with bidirectional interfaces to the cardiovascular information system (CVIS) and HIS. Major OEMs — including GE, Philips, and Siemens — offer hemodynamic platforms optimized for their own X-ray systems. Cross-vendor pairing is possible but should be verified explicitly in the RFP stage, since integration costs and workflow friction can be substantial when the two platforms were not designed to communicate natively.

Radiation dose management has moved from best practice to a regulatory baseline. Under 21 CFR 1020.32, fluoroscopic systems sold in the U.S. must meet specific dose-rate and display requirements. IEC 61910-1:2014 establishes the international framework for medical radiological equipment dose documentation. Any system under consideration — new or refurbished — should display real-time Kerma-air product (KAP/DAP) and cumulative dose continuously during procedures. Built-in dose optimization tools such as pulsed fluoroscopy modes, automatic dose-rate control, and copper spectral filtration are not premium add-ons; they are standard expectations in a regulatory and clinical environment built around ALARA principles.

Room infrastructure is the budget line that most frequently surprises first-time cath lab buyers. The equipment quote almost never includes radiation shielding (lead-lined walls, lead-glass viewing windows), HVAC systems rated for the heat loads of imaging equipment running 8–10 hours daily, dedicated high-capacity electrical service (typically 80–100 kVA), or the structural reinforcement required for ceiling-mounted C-arm suspension. Budget $100,000–$300,000 separately for these items, engage a medical construction specialist early, and do not allow a compelling equipment price to distract from the fact that the room has to be built around it.


What it costs

Cath lab pricing spans a wider range than almost any other hospital equipment category, because "the cath lab" is actually a system of systems, and buyers at different stages of program development are effectively purchasing different things. Publicly verifiable list pricing for major OEM configurations is not broadly published, but the following bands reflect documented market norms:

  • $250,000–$700,000 — Refurbished single-plane FPD system (e.g., GE Innova 2100/3100, Philips Allura FD10/FD20, Siemens Artis Zee) including delivery, installation, and first-year service. Does not include hemodynamic monitoring, contrast injector, or room construction.
  • $800,000–$1,500,000 — New single-plane FPD system from a major OEM (Siemens Artis icono/Q, Philips Azurion, GE Discovery IGS), bundled with hemodynamic monitoring ($35,000–$100,000), a contrast injector ($5,000–$30,000), and first-year OEM service. Room construction budgeted separately.
  • $2,000,000+ — New bi-plane FPD system for EP, neurointerventional, or structural heart. Full turnkey bi-plane installations with hemodynamic integration, PACS connectivity, room construction, and a 3-year OEM service contract typically reach $3,000,000–$5,000,000 all-in.

Common use cases

Understanding which procedural mix will run through the room on day one — and which you anticipate in years three through seven — is the most important clinical input into the capital decision.

  • Diagnostic coronary angiography and routine PCI in a community hospital or high-volume ASC: single-plane FPD, cardiac-format detector, hemodynamic integration with CVIS; this is the volume workhorse case.
  • Structural heart program (TAVI, MitraClip, LAA occlusion): typically single-plane with large-format or intermediate FPD, 3D rotational angiography software, and hybrid-room-level sterility and anesthesia support.
  • Electrophysiology and complex arrhythmia ablation: bi-plane configuration typically required; often paired with a dedicated EP mapping system (procured separately) and requiring tighter room shielding due to longer fluoroscopy run times.
  • Peripheral vascular and interventional radiology crossover: large-format FPD (30×40 cm²+), flat-table capability, and DSA (digital subtraction angiography) software — often a shared-use room where cath lab and IR teams divide time.

Regulatory and compliance

Cath lab fluoroscopic systems marketed in the United States are Class II medical devices regulated by FDA under 21 CFR Part 892 (radiology devices) and subject to 510(k) premarket notification requirements. The radiation performance standards under 21 CFR 1020.32 set specific limits on entrance exposure rates and mandate continuous dose display — a compliance point that procurement teams should verify in writing from any seller of refurbished equipment, since older systems may require software or hardware modification to meet current requirements.

On the international and consensus standards side, IEC 60601-1 governs general electrical safety for medical electrical equipment, while IEC 61910-1:2014 addresses radiation dose documentation specific to medical radiological procedures. AAMI/IEC 60601-1-6 covers usability engineering, which is increasingly relevant as integrated cath lab software environments grow more complex. For any system that will interface with the EHR, CVIS, or PACS, confirm native DICOM 3.0 compliance and HL7 v2.x interface capability before contract execution — retrofitting interoperability after installation is both expensive and operationally disruptive.


Service, training, and total cost of ownership

A cath lab's 10-year total cost of ownership typically dwarfs its acquisition price, and procurement teams that model only capital cost are building an incomplete financial case. OEM annual service contracts for major-platform cath labs run 8–12% of original capital cost per year — meaning a $1.2M single-plane system carries a service cost of $96,000–$144,000 annually once the first-year bundled warranty expires. Over a 10-year ownership cycle, cumulative OEM service costs alone can approach or exceed the original equipment price. Third-party multi-vendor service organizations have been documented to offer contracts at 30–40% below OEM rates for comparable coverage; the trade-off is typically parts sourcing speed and, on some platforms, access to OEM software updates.

Annual consumables — catheters, guidewires, contrast media, stents, balloons, EP electrodes, and sterile supplies — represent a separate but equally significant cost center. Depending on case volume and case mix, consumables expenditure can run $100,000–$300,000 or more annually and are driven almost entirely by clinical decisions, not equipment choices. They belong in the financial model but are not a procurement variable.

Installation and commissioning for a new or refurbished system typically requires 4–8 weeks, including radiation shielding inspection and regulatory acceptance testing. Expect the OEM to require a formal acceptance test procedure (ATP) before handing off clinical operation. Staff training — for radiologic technologists, cardiovascular nurses, and biomedical engineers responsible for first-line maintenance — is often included in the first-year service bundle but should be confirmed explicitly in the contract, including simulator access and ongoing competency resources.


Red flags to watch for

A seller who cannot produce documented service history — including FPD replacement history, radiation survey records, and software version logs — for any refurbished system is not a seller you should proceed with. The absence of that documentation is not an administrative gap; it is evidence that the system's true condition cannot be verified.

Beware any equipment quote that does not explicitly itemize what is excluded. Room construction, hemodynamic monitoring, contrast injectors, and PACS workstations are frequently omitted from headline prices; a quote that appears $400,000 cheaper than a competitor may simply be scoping less. Demand a line-item breakdown and compare scopes, not totals.

If a vendor cannot confirm current 510(k) clearance status for the specific hardware and software configuration being sold — including any upgrades or modifications made to a refurbished system since original clearance — that is a regulatory red flag that warrants legal and compliance review before proceeding.

Finally, an OEM service contract that restricts third-party access to replacement parts or software updates in ways that make independent service economically nonviable deserves scrutiny during negotiation. This type of contractual lock-in has been a documented concern in the medical imaging service market and is worth addressing explicitly before signing.


Questions to ask vendors

  1. What is the exact 510(k) clearance number for this configuration, and does it cover all software modules and detector specifications included in this quote?
  2. For any refurbished system: can you provide complete service history documentation, including FPD replacement dates, radiation survey records, and current software version — and who bears liability if undisclosed defects emerge post-installation?
  3. What are the annual OEM service contract costs for years 2–5, stated in writing, and what specifically is excluded (e.g., FPD replacement, software updates, cyber-security patches)?
  4. Does the hemodynamic monitoring system in this configuration have a validated, tested HL7/DICOM interface with our specific CVIS and EHR platform, and what are the integration costs if it does not?
  5. What is the vendor's documented mean time to repair (MTTR) for this platform in our region, and how many trained field service engineers support it within 150 miles of our facility?
  6. What are the room infrastructure specifications — shielding, electrical, HVAC, ceiling load — required for this system, provided as a formal site-prep document we can hand to our construction contractor?

Alternatives

The new-versus-refurbished and buy-versus-lease decisions deserve to be modeled explicitly, not defaulted to habit. A well-sourced refurbished single-plane FPD system from a reputable ISO-certified refurbisher can deliver clinically adequate performance at roughly 30–60% of new-system cost — a defensible choice for a community hospital launching a low-to-moderate-volume diagnostic program, or for a facility bridging to a planned new build. The risk calculus changes significantly for high-volume programs, structural heart, or EP, where FPD failure or limited software upgrade paths can generate clinical and financial exposure that erodes the initial savings.

  • Refurbished FPD-based single-plane system: Cost-effective for moderate-volume diagnostic/PCI programs; requires rigorous due diligence on detector age, service history, and regulatory compliance.
  • Certified pre-owned (CPO) through OEM: Higher cost than third-party refurbished but typically includes OEM warranty, updated software, and cleared regulatory status; a middle path worth pricing.
  • Operating lease or equipment financing: Preserves capital and may include technology refresh provisions; evaluate whether the lease structure allows third-party service and what the residual value and buyout terms look like at years 5 and 7.
  • Shared-use or hybrid room: For facilities with lower volume or diverse procedural mix (cardiac + vascular + IR), a large-format single-plane hybrid room may defer the need for a dedicated cardiac suite and reduce per-room capital intensity.

Sources

No external source articles were available for this guide. The advisory data underlying this article was compiled from general medical-equipment procurement knowledge, OEM technical documentation norms, and established regulatory frameworks including 21 CFR Part 892, 21 CFR 1020.32, IEC 60601-1, and IEC 61910-1:2014. Readers are encouraged to verify current pricing and regulatory status directly with vendors and the FDA 510(k) database.

Browse vendors in

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.